ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Haemophilus Influenzae Type B Vaccine Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-4G938
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Haemophilus Influenzae Type B Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Haemophilus Influenzae Type B Vaccine Market Insights, Forecast to 2030

Code: QYRE-Auto-4G938
Report
December 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Merck
Sanofi
GlaxoSmithKline PLC
Takeda Pharmaceuticals Company
Walvax Biotechnology
Lanzhou Institute of Biologica
Immunize BC

Haemophilus Influenzae Type B Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Haemophilus Influenzae Type B Vaccine Market

Haemophilus Influenzae Type B Vaccine Market

Haemophilus influenzae b is the leading cause of death and morbidity in children, and its six entities are meningitis, bacterial pneumonia, epiglottitis, septicaemia, cellulitis and bone and joint infections.HIB disease is the cause of about 90 percent of child deaths each year.HIB vaccines are effective and safe for infants because they contain polyribonitol phosphate that binds to proteins in response to meningitis and pneumonia in children.
The global Haemophilus Influenzae Type B Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Haemophilus Influenzae Type B Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Haemophilus Influenzae Type B Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Haemophilus Influenzae Type B Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Haemophilus Influenzae Type B Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Haemophilus Influenzae Type B Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Haemophilus Influenzae Type B Vaccine sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Haemophilus Influenzae Type B Vaccine Market Report

Report Metric Details
Report Name Haemophilus Influenzae Type B Vaccine Market
CAGR 5%
Segment by Type
Segment by Application
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, GlaxoSmithKline, Takeda Pharmaceuticals Company, Walvax Biotechnology, Lanzhou Institute of Biologica, Immunize BC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Haemophilus Influenzae Type B Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Haemophilus Influenzae Type B Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Haemophilus Influenzae Type B Vaccine sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Haemophilus Influenzae Type B Vaccine Market report?

Ans: The main players in the Haemophilus Influenzae Type B Vaccine Market are Sanofi, GlaxoSmithKline, Takeda Pharmaceuticals Company, Walvax Biotechnology, Lanzhou Institute of Biologica, Immunize BC

What are the Application segmentation covered in the Haemophilus Influenzae Type B Vaccine Market report?

Ans: The Applications covered in the Haemophilus Influenzae Type B Vaccine Market report are Hospital, Research Institutions, Pharmaceutical and Biotechnology Companies, Academic Institutions, Other

What are the Type segmentation covered in the Haemophilus Influenzae Type B Vaccine Market report?

Ans: The Types covered in the Haemophilus Influenzae Type B Vaccine Market report are Liquid Monovalent HIB, Liquid Combination HIB, Lyophilized Monovalent HIB, Lyophilized Combination HIB

Recommended Reports

Pediatric Vaccines Market

Influenza Vaccine Segment

Vaccine Supply Chain

1 Study Coverage
1.1 Haemophilus Influenzae Type B Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Liquid Monovalent HIB
1.2.3 Liquid Combination HIB
1.2.4 Lyophilized Monovalent HIB
1.2.5 Lyophilized Combination HIB
1.3 Market by Application
1.3.1 Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Research Institutions
1.3.4 Pharmaceutical and Biotechnology Companies
1.3.5 Academic Institutions
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Haemophilus Influenzae Type B Vaccine Sales Estimates and Forecasts 2019-2030
2.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Region
2.2.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2019-2024)
2.2.3 Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2025-2030)
2.2.4 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2019-2030)
2.3 Global Haemophilus Influenzae Type B Vaccine Sales Estimates and Forecasts 2019-2030
2.4 Global Haemophilus Influenzae Type B Vaccine Sales by Region
2.4.1 Global Haemophilus Influenzae Type B Vaccine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Haemophilus Influenzae Type B Vaccine Sales by Region (2019-2024)
2.4.3 Global Haemophilus Influenzae Type B Vaccine Sales by Region (2025-2030)
2.4.4 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers
3.1.1 Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers (2019-2024)
3.1.2 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Haemophilus Influenzae Type B Vaccine in 2023
3.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers
3.2.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (2019-2024)
3.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Haemophilus Influenzae Type B Vaccine Revenue in 2023
3.3 Global Key Players of Haemophilus Influenzae Type B Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Haemophilus Influenzae Type B Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Haemophilus Influenzae Type B Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Haemophilus Influenzae Type B Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Haemophilus Influenzae Type B Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Haemophilus Influenzae Type B Vaccine Sales by Type
4.1.1 Global Haemophilus Influenzae Type B Vaccine Historical Sales by Type (2019-2024)
4.1.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Sales by Type (2025-2030)
4.1.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Type
4.2.1 Global Haemophilus Influenzae Type B Vaccine Historical Revenue by Type (2019-2024)
4.2.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Haemophilus Influenzae Type B Vaccine Price by Type
4.3.1 Global Haemophilus Influenzae Type B Vaccine Price by Type (2019-2024)
4.3.2 Global Haemophilus Influenzae Type B Vaccine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Haemophilus Influenzae Type B Vaccine Sales by Application
5.1.1 Global Haemophilus Influenzae Type B Vaccine Historical Sales by Application (2019-2024)
5.1.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Sales by Application (2025-2030)
5.1.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Application
5.2.1 Global Haemophilus Influenzae Type B Vaccine Historical Revenue by Application (2019-2024)
5.2.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Haemophilus Influenzae Type B Vaccine Price by Application
5.3.1 Global Haemophilus Influenzae Type B Vaccine Price by Application (2019-2024)
5.3.2 Global Haemophilus Influenzae Type B Vaccine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Haemophilus Influenzae Type B Vaccine Market Size by Type
6.1.1 US & Canada Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2030)
6.1.2 US & Canada Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2030)
6.2 US & Canada Haemophilus Influenzae Type B Vaccine Market Size by Application
6.2.1 US & Canada Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2030)
6.2.2 US & Canada Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2030)
6.3 US & Canada Haemophilus Influenzae Type B Vaccine Market Size by Country
6.3.1 US & Canada Haemophilus Influenzae Type B Vaccine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2030)
6.3.3 US & Canada Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Haemophilus Influenzae Type B Vaccine Market Size by Type
7.1.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2030)
7.1.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2030)
7.2 Europe Haemophilus Influenzae Type B Vaccine Market Size by Application
7.2.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2030)
7.2.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2030)
7.3 Europe Haemophilus Influenzae Type B Vaccine Market Size by Country
7.3.1 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2030)
7.3.3 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Haemophilus Influenzae Type B Vaccine Market Size
8.1.1 China Haemophilus Influenzae Type B Vaccine Sales (2019-2030)
8.1.2 China Haemophilus Influenzae Type B Vaccine Revenue (2019-2030)
8.2 China Haemophilus Influenzae Type B Vaccine Market Size by Application
8.2.1 China Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2030)
8.2.2 China Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Haemophilus Influenzae Type B Vaccine Market Size by Type
9.1.1 Asia Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2030)
9.1.2 Asia Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2030)
9.2 Asia Haemophilus Influenzae Type B Vaccine Market Size by Application
9.2.1 Asia Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2030)
9.2.2 Asia Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2030)
9.3 Asia Haemophilus Influenzae Type B Vaccine Sales by Region
9.3.1 Asia Haemophilus Influenzae Type B Vaccine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Haemophilus Influenzae Type B Vaccine Revenue by Region (2019-2030)
9.3.3 Asia Haemophilus Influenzae Type B Vaccine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Novartis Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Merck Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Sanofi Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Recent Developments
11.5 Takeda Pharmaceuticals Company
11.5.1 Takeda Pharmaceuticals Company Company Information
11.5.2 Takeda Pharmaceuticals Company Overview
11.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Takeda Pharmaceuticals Company Recent Developments
11.6 Walvax Biotechnology
11.6.1 Walvax Biotechnology Company Information
11.6.2 Walvax Biotechnology Overview
11.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Walvax Biotechnology Recent Developments
11.7 Lanzhou Institute of Biologica
11.7.1 Lanzhou Institute of Biologica Company Information
11.7.2 Lanzhou Institute of Biologica Overview
11.7.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lanzhou Institute of Biologica Recent Developments
11.8 Immunize BC
11.8.1 Immunize BC Company Information
11.8.2 Immunize BC Overview
11.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Immunize BC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Haemophilus Influenzae Type B Vaccine Industry Chain Analysis
12.2 Haemophilus Influenzae Type B Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Haemophilus Influenzae Type B Vaccine Production Mode & Process
12.4 Haemophilus Influenzae Type B Vaccine Sales and Marketing
12.4.1 Haemophilus Influenzae Type B Vaccine Sales Channels
12.4.2 Haemophilus Influenzae Type B Vaccine Distributors
12.5 Haemophilus Influenzae Type B Vaccine Customers
13 Market Dynamics
13.1 Haemophilus Influenzae Type B Vaccine Industry Trends
13.2 Haemophilus Influenzae Type B Vaccine Market Drivers
13.3 Haemophilus Influenzae Type B Vaccine Market Challenges
13.4 Haemophilus Influenzae Type B Vaccine Market Restraints
14 Key Findings in The Global Haemophilus Influenzae Type B Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Novartis
Merck
Sanofi
GlaxoSmithKline PLC
Takeda Pharmaceuticals Company
Walvax Biotechnology
Lanzhou Institute of Biologica
Immunize BC
List of Tables
    Table 1. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Liquid Monovalent HIB
    Table 3. Major Manufacturers of Liquid Combination HIB
    Table 4. Major Manufacturers of Lyophilized Monovalent HIB
    Table 5. Major Manufacturers of Lyophilized Combination HIB
    Table 6. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Haemophilus Influenzae Type B Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 10. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2019-2024)
    Table 11. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2025-2030)
    Table 12. Global Haemophilus Influenzae Type B Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2019-2024) & (M Doses)
    Table 14. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2025-2030) & (M Doses)
    Table 15. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2019-2024)
    Table 16. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2025-2030)
    Table 17. Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers (2019-2024) & (M Doses)
    Table 18. Global Haemophilus Influenzae Type B Vaccine Sales Share by Manufacturers (2019-2024)
    Table 19. Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 20. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Manufacturers (2019-2024)
    Table 21. Global Key Players of Haemophilus Influenzae Type B Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 22. Haemophilus Influenzae Type B Vaccine Price by Manufacturers 2019-2024 (USD/Dose)
    Table 23. Global Haemophilus Influenzae Type B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Haemophilus Influenzae Type B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilus Influenzae Type B Vaccine as of 2023)
    Table 25. Global Key Manufacturers of Haemophilus Influenzae Type B Vaccine, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of Haemophilus Influenzae Type B Vaccine, Product Offered and Application
    Table 27. Global Key Manufacturers of Haemophilus Influenzae Type B Vaccine, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2024) & (M Doses)
    Table 30. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2025-2030) & (M Doses)
    Table 31. Global Haemophilus Influenzae Type B Vaccine Sales Share by Type (2019-2024)
    Table 32. Global Haemophilus Influenzae Type B Vaccine Sales Share by Type (2025-2030)
    Table 33. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 34. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 35. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2019-2024)
    Table 36. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2025-2030)
    Table 37. Haemophilus Influenzae Type B Vaccine Price by Type (2019-2024) & (USD/Dose)
    Table 38. Global Haemophilus Influenzae Type B Vaccine Price Forecast by Type (2025-2030) & (USD/Dose)
    Table 39. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2024) & (M Doses)
    Table 40. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2025-2030) & (M Doses)
    Table 41. Global Haemophilus Influenzae Type B Vaccine Sales Share by Application (2019-2024)
    Table 42. Global Haemophilus Influenzae Type B Vaccine Sales Share by Application (2025-2030)
    Table 43. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 44. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 45. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2019-2024)
    Table 46. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2025-2030)
    Table 47. Haemophilus Influenzae Type B Vaccine Price by Application (2019-2024) & (USD/Dose)
    Table 48. Global Haemophilus Influenzae Type B Vaccine Price Forecast by Application (2025-2030) & (USD/Dose)
    Table 49. US & Canada Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2024) & (M Doses)
    Table 50. US & Canada Haemophilus Influenzae Type B Vaccine Sales by Type (2025-2030) & (M Doses)
    Table 51. US & Canada Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 52. US & Canada Haemophilus Influenzae Type B Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 53. US & Canada Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2024) & (M Doses)
    Table 54. US & Canada Haemophilus Influenzae Type B Vaccine Sales by Application (2025-2030) & (M Doses)
    Table 55. US & Canada Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 56. US & Canada Haemophilus Influenzae Type B Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 57. US & Canada Haemophilus Influenzae Type B Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. US & Canada Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 59. US & Canada Haemophilus Influenzae Type B Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 60. US & Canada Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 61. US & Canada Haemophilus Influenzae Type B Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 62. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2024) & (M Doses)
    Table 63. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2025-2030) & (M Doses)
    Table 64. Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 65. Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 66. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2024) & (M Doses)
    Table 67. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2025-2030) & (M Doses)
    Table 68. Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 69. Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 70. Europe Haemophilus Influenzae Type B Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 71. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 72. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 73. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 74. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 75. China Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2024) & (M Doses)
    Table 76. China Haemophilus Influenzae Type B Vaccine Sales by Type (2025-2030) & (M Doses)
    Table 77. China Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 78. China Haemophilus Influenzae Type B Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 79. China Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2024) & (M Doses)
    Table 80. China Haemophilus Influenzae Type B Vaccine Sales by Application (2025-2030) & (M Doses)
    Table 81. China Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 82. China Haemophilus Influenzae Type B Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 83. Asia Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2024) & (M Doses)
    Table 84. Asia Haemophilus Influenzae Type B Vaccine Sales by Type (2025-2030) & (M Doses)
    Table 85. Asia Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia Haemophilus Influenzae Type B Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 87. Asia Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2024) & (M Doses)
    Table 88. Asia Haemophilus Influenzae Type B Vaccine Sales by Application (2025-2030) & (M Doses)
    Table 89. Asia Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 90. Asia Haemophilus Influenzae Type B Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 91. Asia Haemophilus Influenzae Type B Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 92. Asia Haemophilus Influenzae Type B Vaccine Revenue by Region (2019-2024) & (US$ Million)
    Table 93. Asia Haemophilus Influenzae Type B Vaccine Revenue by Region (2025-2030) & (US$ Million)
    Table 94. Asia Haemophilus Influenzae Type B Vaccine Sales by Region (2019-2024) & (M Doses)
    Table 95. Asia Haemophilus Influenzae Type B Vaccine Sales by Region (2025-2030) & (M Doses)
    Table 96. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2024) & (M Doses)
    Table 97. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2025-2030) & (M Doses)
    Table 98. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2024) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue by Type (2025-2030) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2024) & (M Doses)
    Table 101. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2025-2030) & (M Doses)
    Table 102. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue by Application (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 105. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2024) & (M Doses)
    Table 108. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2025-2030) & (M Doses)
    Table 109. Novartis Company Information
    Table 110. Novartis Description and Major Businesses
    Table 111. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 112. Novartis Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Novartis Recent Developments
    Table 114. Merck Company Information
    Table 115. Merck Description and Major Businesses
    Table 116. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 117. Merck Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Merck Recent Developments
    Table 119. Sanofi Company Information
    Table 120. Sanofi Description and Major Businesses
    Table 121. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 122. Sanofi Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Sanofi Recent Developments
    Table 124. GlaxoSmithKline Company Information
    Table 125. GlaxoSmithKline Description and Major Businesses
    Table 126. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 127. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. GlaxoSmithKline Recent Developments
    Table 129. Takeda Pharmaceuticals Company Company Information
    Table 130. Takeda Pharmaceuticals Company Description and Major Businesses
    Table 131. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 132. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Takeda Pharmaceuticals Company Recent Developments
    Table 134. Walvax Biotechnology Company Information
    Table 135. Walvax Biotechnology Description and Major Businesses
    Table 136. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 137. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Walvax Biotechnology Recent Developments
    Table 139. Lanzhou Institute of Biologica Company Information
    Table 140. Lanzhou Institute of Biologica Description and Major Businesses
    Table 141. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 142. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Lanzhou Institute of Biologica Recent Developments
    Table 144. Immunize BC Company Information
    Table 145. Immunize BC Description and Major Businesses
    Table 146. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 147. Immunize BC Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Immunize BC Recent Developments
    Table 149. Key Raw Materials Lists
    Table 150. Raw Materials Key Suppliers Lists
    Table 151. Haemophilus Influenzae Type B Vaccine Distributors List
    Table 152. Haemophilus Influenzae Type B Vaccine Customers List
    Table 153. Haemophilus Influenzae Type B Vaccine Market Trends
    Table 154. Haemophilus Influenzae Type B Vaccine Market Drivers
    Table 155. Haemophilus Influenzae Type B Vaccine Market Challenges
    Table 156. Haemophilus Influenzae Type B Vaccine Market Restraints
    Table 157. Research Programs/Design for This Report
    Table 158. Key Data Information from Secondary Sources
    Table 159. Key Data Information from Primary Sources
List of Figures
    Figure 1. Haemophilus Influenzae Type B Vaccine Product Picture
    Figure 2. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Haemophilus Influenzae Type B Vaccine Market Share by Type in 2023 & 2030
    Figure 4. Liquid Monovalent HIB Product Picture
    Figure 5. Liquid Combination HIB Product Picture
    Figure 6. Lyophilized Monovalent HIB Product Picture
    Figure 7. Lyophilized Combination HIB Product Picture
    Figure 8. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Haemophilus Influenzae Type B Vaccine Market Share by Application in 2023 & 2030
    Figure 10. Hospital
    Figure 11. Research Institutions
    Figure 12. Pharmaceutical and Biotechnology Companies
    Figure 13. Academic Institutions
    Figure 14. Other
    Figure 15. Haemophilus Influenzae Type B Vaccine Report Years Considered
    Figure 16. Global Haemophilus Influenzae Type B Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Haemophilus Influenzae Type B Vaccine Revenue 2019-2030 (US$ Million)
    Figure 18. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 19. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2019-2030)
    Figure 20. Global Haemophilus Influenzae Type B Vaccine Sales 2019-2030 ((M Doses)
    Figure 21. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2019-2030)
    Figure 22. US & Canada Haemophilus Influenzae Type B Vaccine Sales YoY (2019-2030) & (M Doses)
    Figure 23. US & Canada Haemophilus Influenzae Type B Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Haemophilus Influenzae Type B Vaccine Sales YoY (2019-2030) & (M Doses)
    Figure 25. Europe Haemophilus Influenzae Type B Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. China Haemophilus Influenzae Type B Vaccine Sales YoY (2019-2030) & (M Doses)
    Figure 27. China Haemophilus Influenzae Type B Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Asia (excluding China) Haemophilus Influenzae Type B Vaccine Sales YoY (2019-2030) & (M Doses)
    Figure 29. Asia (excluding China) Haemophilus Influenzae Type B Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Sales YoY (2019-2030) & (M Doses)
    Figure 31. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue YoY (2019-2030) & (US$ Million)
    Figure 32. The Haemophilus Influenzae Type B Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 33. The Top 5 and 10 Largest Manufacturers of Haemophilus Influenzae Type B Vaccine in the World: Market Share by Haemophilus Influenzae Type B Vaccine Revenue in 2023
    Figure 34. Global Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 35. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2019-2030)
    Figure 36. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2019-2030)
    Figure 37. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2019-2030)
    Figure 38. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2019-2030)
    Figure 40. US & Canada Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2019-2030)
    Figure 41. US & Canada Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2019-2030)
    Figure 42. US & Canada Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2019-2030)
    Figure 43. US & Canada Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2019-2030)
    Figure 44. US & Canada Haemophilus Influenzae Type B Vaccine Sales Share by Country (2019-2030)
    Figure 45. U.S. Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 46. Canada Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 47. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2019-2030)
    Figure 48. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2019-2030)
    Figure 49. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2019-2030)
    Figure 50. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2019-2030)
    Figure 51. Europe Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2019-2030)
    Figure 52. Europe Haemophilus Influenzae Type B Vaccine Sales Share by Country (2019-2030)
    Figure 53. Germany Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 54. France Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 55. U.K. Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 56. Italy Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 57. Russia Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 58. China Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2019-2030)
    Figure 59. China Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2019-2030)
    Figure 60. China Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2019-2030)
    Figure 61. China Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2019-2030)
    Figure 63. Asia Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2019-2030)
    Figure 64. Asia Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2019-2030)
    Figure 65. Asia Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2019-2030)
    Figure 66. Asia Haemophilus Influenzae Type B Vaccine Revenue Share by Region (2019-2030)
    Figure 67. Asia Haemophilus Influenzae Type B Vaccine Sales Share by Region (2019-2030)
    Figure 68. Japan Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 69. South Korea Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 70. China Taiwan Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 71. Southeast Asia Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 72. India Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 73. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2019-2030)
    Figure 75. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2019-2030)
    Figure 77. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2019-2030)
    Figure 78. Middle East, Africa and Latin America Haemophilus Influenzae Type B Vaccine Sales Share by Country (2019-2030)
    Figure 79. Brazil Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 80. Mexico Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 81. Turkey Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 82. Israel Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 83. GCC Countries Haemophilus Influenzae Type B Vaccine Revenue (2019-2030) & (US$ Million)
    Figure 84. Haemophilus Influenzae Type B Vaccine Value Chain
    Figure 85. Haemophilus Influenzae Type B Vaccine Production Process
    Figure 86. Channels of Distribution
    Figure 87. Distributors Profiles
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Haemophilus Influenzae Type B Injection Vaccine Market Research Report 2025
Global Haemophilus Influenzae Type b Conjugate Vaccine Market Research Report 2025
Haemophilus b Conjugate Vaccine Hib Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Acellular Diphtheria Pertussis Haemophilus Influenzae Type B Combined Vaccine Market Research Report 2024
Global 1Type 1 Hib Vaccine Market Research Report 2024
Global Pneumonia Vaccine Market Insights Forecast to 2030
Meningococcal Group B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Meningococcal Disease Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Bacterial Disease Vaccines Market Research Report 2024
Global Streptococcus Group B Antibodies Market Research Report 2024
Global Haemophilus Influenzae Nucleic Acid Detection Kit Market Research Report 2024
Global Prevent Meningitis Vaccine Market Research Report 2025
Human Bacterial Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Meningococcal Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Haemophilus Influenzae Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hib Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Meningococcal Infections Vaccine Market Insights Forecast to 2030
Global Meningitis Vaccine Market Research Report 2025
Global Vaccines For Children Market Insights Forecast to 2030

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions